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Human parainﬂuenza virus 3 (HPIV3) commonly causes respiratory disorders in infants and
young children. Monoclonal antibodies (MAbs) have been produced to several components
of HPIV3 and commercially available. However, the utility of these antibodies for several
immunological and proteomic assays for understanding the nature of HPIV3 infection
remain to be characterized. Herein, we report the development and characterization of
MAbs against hemagglutinin-neuraminidase (HN) of HPIV3. A recombinant full-length
HPIV3-HNwas successfully synthesized using the wheat-germ cell-free protein production
system. After immunization and cell fusion, 36 mouse hybridomas producing MAbs
to HPIV3-HN were established. The MAbs obtained were fully characterized using
ELISA, immunoblotting, and immunoﬂuorescent analyses. Of the MAbs tested, single
clone was found to be applicable in both ﬂow cytometry and immunoprecipitation
procedures. By utilizing the antibody, we identiﬁed HPIV3-HN binding host proteins via
immunoprecipitation-basedmass spectrometry analysis.The newly-developedMAbs could
thus be a valuable tool for the study of HPIV3 infection as well as the several diagnostic
tests of this virus.
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INTRODUCTION
Human parainﬂuenza viruses (HPIVs) are major causes of lower
respiratory infections in infants, young children, the immuno-
compromised, the chronically ill, and the elderly (Glezen et al.,
1984; Counihan et al., 2001; Weinberg et al., 2009). HPIVs belong
to the Paramyxoviridae family of medium-sized enveloped viruses
and their genomes are organized on a single negative-sense strand
of RNA. Of the four predominant serotypes of HPIV, the HPIV3
is the most frequently detected in viral infections in respiratory
tracts. In fact, HPIV3 is second only to respiratory syncytial
virus (RSV) as a cause of pneumonia and bronchiolitis in infants
and young children. The HPIV3 genome contains approximately
15,000 nucleotides encoding at least six common structural pro-
teins (3′-N-P-C-M-F-HN-L-5′; Storey et al., 1984; Tashiro and
Homma, 1985; Wechsler et al., 1985). The two envelope glyco-
proteins, hemagglutinin-neuraminidase (HN) and fusion (F), are
necessary for viral entry, cell-fusion and syncytium formation
(Horvath et al., 1992; Hu et al., 1992; Takimoto et al., 2002; Porotto
et al., 2012).
TheHNprotein is found on the lipid envelope of HPIVs, where
it likely exists as a tetramer. HN is important for HPIV3 infection
of host cells because it functions in virus-host cell attachment via
sialic acid receptors and in virus release from cells with its neu-
raminidase activity (Huberman et al., 1995; Porotto et al., 2001;
Chu et al., 2013). HN can be recognized by the host immune sys-
tem and antibodies against epitopes within HN can neutralize
its activity through the inhibition of the function and/or activity
of either hemagglutinin or neuraminidase. Therefore, character-
ization of the protein structure and function of HN is of great
importance for the understanding of HPIV3 infection and the
host immunity against this virus.
Polyclonal antibodies and monoclonal antibodies (MAbs)
against HPIV3 antigens have previously been generated, and
animal antiserum to HPIV3 HN is also commercially available.
However, the antibodies demonstrated cross-reactivity to other
HPIV family viruses and exhibited relatively high non-speciﬁc
background staining in immunoassays (Goswami and Russell,
1983; Waner et al., 1985). MAbs have been also produced to
several components of HPIV3 (van Wyke Coelingh et al., 1985;
Rydbeck et al., 1986). Although these commercially available
MAbs have been shown to be speciﬁc, the utility of these anti-
bodies for several immunological and/or proteomic analyses for
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understanding the nature of HPIV3 infection have not been fully
delineated.
In our current study,we utilized the innovativewheat germ cell-
free protein production system to generate the antigen protein.
The main advantage of the cell-free protein system is the synthe-
sis of proteins that are properly folded and that possess biological
activity because the proteins are expressed in a eukaryotic cell sys-
tem. Moreover, this system is capable of producing toxic proteins,
such as viral antigens, that cause severe cytotoxicity or interfer-
ence with host cellular physiology. By utilizingHPIV3-HNprotein
synthesized by the wheat cell-free system, we established multi-
ple hybridoma clones producing MAbs that speciﬁcally targeted
the viral antigen and were applicable for several immunoas-
says. Furthermore, we used the MAbs in proteomic analyses
for identifying host proteins that potentially act as HN binding
partners.
MATERIALS AND METHODS
CONSTRUCTION OF WHEAT GERM CELL-FREE EXPRESSION VECTOR
Ampliﬁcation of HN fragment from HPIV3 (Strain C243)
genome was performed with the following primers: for-
ward (5′-AGGAGTAAAGTTACGCAATCCAA) and reverse (5′-
ATATTTCCCTTTTGTCTATTGTCTG). Forproducing the expres-
sion vector of wheat germ cell-free system, The HN open-
reading frame was ampliﬁed by PCR using the forward primer
(5′-GAGAGGATCCCATGGAATACTGGAAGCAT) and reverse
primer (5′-GAGAGCGGCCGCTTAACTGCAGCTTTTTGGA).
The ampliﬁed fragment was subcloned using BamH I and Not
I into pEU-His or pEU-bls-S1 (bls; biotin ligase site) vectors.
Biotinylated HN mutants were generated using the PrimeSTAR
Mutagenesis Basal kit (TakaraBio, Otsu, Japan) according to the
manufacturer’s instructions.
HN protein fragments comprising CT, TM, and stalk
regions were generated by the wheat cell-free system based
on the template cDNA ampliﬁed from clinical isolates of
HPIV1 (GeneBank No. JQ901977; Beck et al., 2012), HPIV2
(GeneBankNo. AF533010; Skiadopoulos et al., 2003), andMumps
(GeneBankNo.AB699704;Momoki,2013) using followingprimer
sets. HPIV1: (5′-ATGCTTATACTCTGGAGTCAAGA) and (5′-
TCTAGCAAAACRTGAAGTTGAG); HPIV2: (5′-AAAAACCTA-
AAATAAGCACGAA); and (5′-CCATTCTGGCCTATATYATAAT),
Mumps: (5′-TTACTTATAAGACTGCGGTGC) and (5′-CTTGCA-
ATGAGTTCTACTCTGA). Synthetic cDNA encoding the CT,
TM and stalk regions of Sendai virus (UniProtKB entry no.
P04853; Miura et al., 1985) was generated by Operon Biotech-
nologies (Huntsville, WI, USA). The ampliﬁed fragments were
subcloned into pEU-bls-S1 vectors using In-fusion cloning system
(TakaraBio) according to the manufacturer’s instructions.
CELL-FREE PROTEIN SYNTHESIS AND PURIFICATION
In vitro transcription and cell-free protein synthesis were per-
formed as described (Takai and Endo, 2010; Takai et al., 2010). For
cell-free protein synthesis, the ENDEXT Wheat Germ Expression
S Kit (CellFree Sciences, Yokohama, Japan) was used accord-
ing to the manufacturer’s instructions for the bilayer translation
method. GST fusion and Biotinylated proteins were produced as
previously described (Sawasaki et al., 2008; Takahashi et al., 2012).
His-HPIV3-HN protein, used for the generation of hybridoma,
was synthesized using the robotic synthesizer (Protemist XE; Cell-
Free Sciences) according to the manufacturer’s instructions. The
cell-free translation reaction mixture (15 ml) was separated into
soluble and insoluble fractions by centrifugation at 15,000 rpm
for 15 min. The insoluble fraction was lysed by the addition of
8 M Urea at room temperature for 6 h, then mixed with Ni-
sepharose High Performance beads (GE Healthcare, Waukesha,
WI, USA) in the presence of 20 mM imidazole. The beads were
washed three times with washing buffer (20 mM Tris–HCl pH
7.5, 500 mM NaCl) containing 40 mM imidazole. His-HN pro-
teins were then eluted with washing buffer containing 8 M Urea,
500 mM imidazole. Amicon Ultra centrifugal ﬁlters (Millipore,
Bedford,MA,USA) were used to concentrate the puriﬁed His-HN
proteins by approximately 10- to 20-fold. The protein concen-
tration was determined using the Bradford method with bovine
serum albumin (BSA) as a protein standard.
IMMUNIZATIONS AND GENERATION OF HYBRIDOMAS
Monoclonal antibodies speciﬁc for HPIV3-HN were generated
using the previously described hybridoma technology (Kimura
et al., 1994). In brief, 300μg of N-terminal, His-tagged full-length
HPIV3-HN protein was injected into the footpad of Balb/c mice
using keyhole limpet hemocyanin as an adjuvant. Four weeks later,
spleen cells were isolated and fused to the myeloma cell line SP2/O
using polyethylene glycol 1500 (PEG 1500) as previously described
(Kimura et al., 1996). Isotype determination was performed with
the mouse MAb isotyping test kit (Bio-Rad, Hercules, CA, USA)
according to the manufacturer’s protocol.
ELISA
Microtiter plates coated with HPIV3-HN were incubated with
threefold serial dilutions of each antibody (starting from 1:300
dilution of a hybridoma culture supernatant). After incubation
with a peroxidase-conjugated secondary antibody and washing
with PBS, the colorimetric signal of tetramethylbenzidine was
detected by measuring the absorbance at 405 nm (Abs) using a
plate reader.
IMMUNOBLOTTING
Recombinant HPIV3-HN proteins (equivalent to ∼100 ng) or
HPIV3-infected HeLa cell lysates were separated by 10% SDS-Gel
and transferred onto a PVDF membrane (Millipore). The mem-
branewas then soaked inTris-buffered saline (TBS) containing 5%
(w/v) skim milk for 1 h and incubated with a MAb (hybridoma
supernatant, 1:10 dilution) in TBS containing 0.1% (v/v) Tween-
20 (TBST) overnight at 4◦C. After washing three times with TBST,
themembrane was incubated for 1 h in TBST containing goat-anti
mouse IgG-HRP antibody (1:10000; GE Healthcare, Bucking-
hamshire, UK). After washing three times in TBST, the blot was
detected with ImmobilonWestern Chemiluminescent HRP Sub-
strate (Millipore) using FluorChem FC2 (Alpha Innotech, Santa
Clara, CA, USA) in accordance to the manufacturer’s protocol.
IMMUNOPRECIPITATION
HeLa cells were infected with HPIV3 (Strain C243) at multiplicity
of infection (MOI) of 100 for 48 h. The cells were lysed with
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immunoprecipitation buffer (50 mM Tris-HCl pH 7.5, 100 mM
NaCl, 0.5%NP-40, 200μMPMSF,50μMVO4, 2μg/mlAprotinin,
5 μg/ml Leupeptin, 1 μg/ml Pepstatin A). For immunoprecip-
itation assay, cell lysate or wheat germ cell extract generating
full-length HPIV3-HN was incubated with the individual MAb
(hybridoma supernatant), preclearing overnight using proteinA/G
sepharose beads, for 2 h at 4◦C. After washing three times with
immunoprecipitation buffer, immunocomplexes were eluted from
the beads with 2x SDS sample buffer. Then, the bound protein was
analyzed by immnoblotting.
IMMUNOFLUORESCENCE
HeLa cells were grown on coverslips for 24 h and the cells were
infected with HPIV3 (MOI = 100); mock-infected cells served as
the control. At 48 h post-infection, the cells were washed with
PBS before ﬁxation with 3% formalin in PBS at room temperature
for 15 min. Cells were washed twice with PBS for 5 min followed
by 100% methanol for 10 min at −20◦C. Cells were permeabi-
lized with PBS containing 0.05% Triton X-100 for 10 min at room
temperature. The cells were incubated with individual primary
antibodies for 1 h at room temperature. After being washed twice
with PBS, the cells were incubated with secondary antibodies for
1 h at room temperature. The nucleus was counterstained with
4′,6-diamidino-2-phenylindole (DAPI). Microscopic imaging was
performed with an FV1000-D confocal laser scanning microscope
(Olympus, Tokyo, Japan) equipped with a 60x oil-immersion
objective.
FLOW CYTOMETRY
HeLa cellswere seeded in 6-well plates at a concentrationof 2× 105
per well 24 h before infection, and the cells were washed with
medium containing 0.0001% trypsin and infected with HPIV3
(MOI = 100); mock-infected cells were used as a control. At
4 days post-infection, cells were harvested in PBS containing 5mM
EDTA and washed twice with PBS. The cells were then incu-
bated with either MAbs (hybridoma supernatant; 5X dilution)
or non-immunized hybridoma supernatant in PBS containing 2%
Blocking One (NACALAI TESQUE, INC., Kyoto, Japan) for 1 h at
room temperature. After being washed twice with PBS, the cells
were incubated with phycoerythrin (PE)-conjugated anti-mouse
IgG antibodies (Beckman Coulter, Fullerton, CA, USA) for 1 h at
room temperature. Flow cytometric analysis of the cells (10,000
cells per sample) was performed on a FACScanto II instrument
(BD Biosciences, San Jose, CA, USA).
EPITOPE MAPPING AND SPECIFICITY OF MAbs USING ALPHASCREEN
ASSAY
The AlphaScreen assay was performed using 384-well ProxiPlates
(PerkinElmer, Boston, MA, USA). Biotinylated virus proteins
or GST (negative control) were incubated with a 40-fold dilu-
tion of MAbs (hybridoma supernatant) in 15 μl of binding
mixture containing reaction buffer (100 mM Tris-HCl, pH 7.5,
1 mg/ml BSA, 0.01% Tween-20) at 26◦C for 30 min. Then,
combine 10 μl of the detection mixture containing 0.1 μl pro-
tein G-conjugated acceptor beads and 0.1 μl streptavidin-coated
donor beads (AlphaScreen IgGdetection kit, PerkinElmer) in reac-
tion buffer were incubated at 26◦C for 1 h. Antigen-antibody
interactions were analyzed using an Envision microplate reader
(PerkinElmer).
PROTEOMIC ANALYSIS
Cell lysate from HPIV3-infected or mock-infected HeLa cells
were immunoprecipitated with #21 MAb. The binding proteins
were separated by SDS-PAGE and transferred to PVDF mem-
branes. For LC-MS/MS analysis, the membranes digested with
trypsin. LC-MS/MS analysis was performed using a TripleTOF
MS (TripleTOF 5600 system, AB SCIEX, Foster City, CA, USA)
and the Analyst version 1.6 TF (AB SCIEX) coupled to an DiNa-
AP (KYA Technologies, Tokyo, Japan). Prior to injection into
the mass spectrometer, the tryptic digests were ﬁltered through
a Ultrafree-MC, GV 0.22 μm ﬁlter (Millipore), then loaded onto
a reverse phase pre-column (HiQ sil C18W-3, 500μm id × 1 mm,
KYA Technologies) and resolved on a nanoscale HiQ sil C18W-
3 (100 μm id × 10 cm; KYA Technologies) at a ﬂow rate of
200 nL/min with a gradient of acetonitrile/0.1% (v/v) formic
acid. Peptides were separated using a 30 min gradient from 5
to 100% solvent B [0.1% (v/v) formic acid/80% (v/v) acetoni-
trile]. Solvent A was 0.1 % (v/v) formic acid/2% (v/v) acetonitrile.
The obtained MS and tandem-MS data were searched against the
human protein sequences in the Swiss-Prot database (version Jan
2013, 20233sequences) using the Protein Pilot software 4.5 (AB
SCIEX).
RESULTS
PRODUCTION OF MAbs
In our current study, we attempted to produce the full-length
HPIV3-HN by the wheat cell-free production system (Figure 1A).
Complementary DNA encoding HPIV3-HN open-reading frame
was sub-cloned into pEU-His, the expression vector designed
speciﬁcally for the wheat germ cell-free system for expressing
His-tagged protein. Consequently, His-tagged HPIV3-HN pro-
tein was synthesized by this procedure in a large scale. Since
HPIV3-HN exhibited high insolubility in regular buffer, the
protein was suspended in the buffer including 8 M urea. This
suspended His-tagged HPIV3-HN was further puriﬁed using Ni-
sepharose followed by the elusion with imidazole. Balb/c mice
were then immunized with puriﬁed full-length HPIV3-HN pro-
tein. After 4 weeks, splenocytes were isolated and hybridomas
were created (Figure 1A). Finally, 36 stable hybridomas were
obtained and designated #1 to #36. The resulting hybridomas
were screened by ELISA with plates coated with HPIV3-HN
protein conjugated with BSA. Of the 36 hybridoma clones estab-
lished, seven clones (#4, #5, #7, #10, #14, #21, #23) exhib-
ited relatively high absorbances (Figure 1B). Titration analyses
with diluted hybridoma supernatants or antigenic HN protein
revealed that these seven antibodies had higher speciﬁcities and
intensities than control hybridoma supernatants (Figure 1C).
These seven hybridomas were processed for further characteri-
zation.
IMMUNOBLOTTING ANALYSES OF MAbs
We next tested the MAbs in immunoblotting analysis. First,
recombinant HPIV3-HN protein was separated by SDS-PAGE fol-
lowed by immunoblotting with MAbs isolated from the seven
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FIGURE 1 | Production of hybridoma cells generating anti-HPIV3-HN
antibodies. (A) Schematic diagram of hybridoma cells production generating
anti-HPIV3-HN monoclonal antibody (MAb). The recombinant Histidine-tagged
recombinant HPIV3-HN (His-HN) protein was produced by wheat germ
cell-free system and then puriﬁed by nickel-chelated sepharose beads in the
presence of 8 M urea. The puriﬁed protein was separated by SDS-PAGE and
visualized by CBB-staining. Puriﬁed His-HN protein was injected into the
footpad of Balb/c mice. After 4 weeks, immunized mouse splenocytes were
fused with myeloma cells and then 36 hybridoma cells were established.
SP6, SP6 promoter sequence; E01, translation enhancer sequence; His,
Histidine-tagged sequence; TEV; TEV protease recognized sequence. (B,C)
The speciﬁcity of MAbs (hybridoma supernatant) evaluated by ELISA. The
speciﬁcity of 36 MAbs in 2700-fold dilution was determined (B). The black
arrows indicate the selected MAbs while the white arrow depicts a selected
clone as a negative control (clone no. #30). The selected eight MAbs were
diluted at serial points and analyzed by ELISA (C).
hybridomas. As shown in Figure 2A, all seven MAbs recognized a
single band that corresponded to the recombinant protein. Next,
immunoblotting analysis was performed with cell lysates from
HeLa cells either infected- or mock-infected with HPIV3. The all
seven MAbs detected a 63 kDa protein band that was consistent
with the molecular mass of the HN protein (Figure 2B). No other
bands were detected by the MAbs indicating that they speciﬁcally
recognized HN.
IMMUNOFLUORESCENT ANALYSIS
Wenext performed an immunoﬂuorescent (IF) analysis of HPIV3-
infected HeLa cells with seven MAbs (Figure 2C). Three of the
MAbs (#7, #21, and #23) exhibited prominent IF staining of the
infected cells, while the other four MAbs had no detectable IF
staining. The IF staining with the antibodies revealed that HN
protein exhibited granular staining pattern throughout cytoplasm
andplasmamembrane inHPIV3-infected cells (Figure 2D),which
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FIGURE 2 | Immunoblotting and immunofluorescent analysis.
(A,B) Detection sensitivity of the MAbs for recombinant His-HN (A) or
HPIV3-infected cell lysate (B). Recombinant HPIV3-HN (100 ng) was
separated using 12.5% SDS-gel and transferred to a PVDF membrane,
followed by incubation with MAbs (hybridoma supernatants) at a 1:10
dilution (A). HeLa cells were infected or mock-infected with HPIV3.
After 48 h, cells were lysed with SDS-PAGE loading buffer. The total
protein was separated in 12.5% SDS-gel and immunobloted with
indicated MAbs (B). (C,D) Immunoﬂuoresent analysis of HN (red) in
HPIV3-infected HeLa cells. HeLa cells were infected or mock-infected
with HPIV3. After 48 h, cells were ﬁxed, and then stained with
MAbs (hybridoma supernatant; red) and DAPI (blue). Confocal
microscopic analysis was performed at 40× (C) and at 600×
magniﬁcations (D).
was consistent with previous studies (Ali and Nayak, 2000; Stone
and Takimoto, 2013). The control mock-infected cells did not
show any signals when stained with the antibodies (Figure 2C).
We thus selected the three MAbs (#7, #21, and #23) for further
characterization.
IMMUNOPRECIPITATION
We next examined whether these selected antibodies were use-
ful in immunoprecipitation analysis. The wheat germ extract
containing full-length HPIV3-HN with glutathione-S-transferase
(GST) tag was incubated with protein A/G-coated sepharose
beads (GE Helthcare) together with the three selected antibodies
or non-immunized mouse IgG antibody. The precipitated sam-
ples were subjected to immunoblotting analysis with anti-GST
antibody. The GST tagged HN protein was precipitated by all
selected antibody (#7, #21, and #23) but not non-immunized IgG
(Figure 3A).
FLOW CYTOMETRY ANALYSIS
We next addressed the usability of the antibodies #7, #21, and #23
in ﬂow cytometry analysis. HeLa cells infected with HPIV3 were
stained with the antibodies and then subjected to FACS analysis.
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FIGURE 3 | Immunoprecipitation and flow cytometry assay.
(A) Recombinant GST-HPIV3-HN or GST protein was immnoprecipitated
with either #7, #21, #23 MAbs, or IgG (negative control), respectively. Then
bound proteins were analyzed with immunoblotting using anti-GST
antibody. (B) HPIV3-infected or uninfected HeLa cells were harvested at
4 days post-infection, followed by incubation with indicated MAbs. The cells
were then ﬁxed and stained with anti-mouse secondary antibody. The
population of stained cells was calculated by ﬂow cytometry. The shaded
histogram shows negative hybridoma supernatant and the bold line shows
speciﬁc MAbs.
Our results demonstrated that only #21 MAbs could speciﬁcally
detect virus-infected cell populations, and distinguished between
viral-infected anduninfected cell populationwithﬂowcytometory
(Figure 3B).
EPITOPE MAPPING OF MAbs
To determine the binding domain of the MAbs within the
HPIV3-HN protein, we synthesized six different deletion
mutants of HPIV3-HN as depicted in Figure 4A. All of
the deletion mutants contained N-terminal biotin tag were
incubated with the antibodies (#7, #21, or #23), followed
by the addition of AlphaScreen streptavidin donor and pro-
tein A acceptor beads, as depicted in Figure 4B. The
reactivity was measured and calculated by the level of the
AlphaScreen luminescent signal. The results showed that two
MAbs (#7 and #23) reacted against the cytoplasmic tail
(CT) of HPIV3-HN whereas #21 MAb detected extracellu-
lar stalk region of the protein (Figures 4C–E). This result
is fully consistent with the result of ﬂow cytometry analysis
(Figure 3B).
SPECIFICITY OF MAb
We next investigate the speciﬁcity of MAbs using HN protein
frangments derived from HPIV1, Sendai virus (SeV), HPIV2, and
Mumpus virus (MuV). Partial HN protein fragments containing
cytoplasmic tail (CT), transmembrane domain (TM), and stalk
region were produced with a N-terminal biotin tag by wheat cell-
free system, and then incubated with the antibodies (#7, #21,
or #23) followed by the AlphaScreen (Figure 5A). The antigen
reactivity was measured based on the level of the AlphaScreen
luminescent signal (Figure 5B). Notably, there was no cross-
reactivity to HN proteins derived from other Paramyxoviruses
except for HPIV3. This was also conﬁrmed by immunoblotting
analysis (Figure 5C). These results indicate the speciﬁcity of the
antibodies for HPIV3-HN.
PROTEOMIC ANALYSIS
We next utilized our newly developed #21 MAb for the iden-
tiﬁcation of host proteins that bind to HPIV3-HN during
HPIV3 infection. Cell lysate from HPIV3-infected or mock-
infected cells were immunoprecipitated with #21 MAb. Precip-
itated samples were collected and then digested with trypsin
followed by LC-MS/MS analysis (Figure 6A). Annotation anal-
ysis using the Swiss-Prot database revealed that 10 proteins
were putative HN binding proteins (Figure 6B). Based on
the number of corrected peptides, top four proteins (HSP70,
HSP90, tubulin, alpha 1c, and SERPINA3) were selected as
the most likely candidates for association with HN and sub-
jected to further binding analysis. The pull-down analysis
of the host proteins with recombinant HPIV3-HN was per-
formed. The subsequent immunoblotting analysis demonstrated
that HPIV3-HN could indeed interact with these four pro-
teins (Figure 6C). These results demonstrate the availability
of our newly-developed antibody in comprehensive proteomic
analysis.
DISCUSSION
Herein we produced HPIV3-HN proteins by the wheat cell-free
system, and created MAbs that selectively target the HPIV3-HN
protein. Characterization of the most potent MAb conﬁrmed the
antigen-speciﬁcity and usability in various applications includ-
ing immunoblotting, immnoﬂuorescent, ﬂow cytometry, and
immunoprecipitation analyses. Furthermore, the MAb could cap-
ture the endogenous HN protein from HPIV3-infected cells to
identify HN-binding host proteins via mass spectrometry-based
proteomic analysis. Our current results demonstrated the genera-
tion of useful antibody against HPIV3-HN and also shed new light
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FIGURE 4 | Epitope mapping for generated antibodies. (A) Schematic
diagram of seven deletion mutants of HPIV3-HN for epitope mapping. These
proteins were produced as N-terminal biotinylated protein by wheat germ
cell-free system. (B) Schematic diagram of the AlphaScreen assay used to
detect the binding of MAb to full-length or deletion mutants of HPIV3-HN.The
interaction between antibodies and recombinant proteins was monitored by
AlphaScreen with protein A-conjugated acceptor beads and
streptavidin-coated donor. Upon excitation at 680 nm, singlet oxygen
molecules were produced from the donor beads, which reacted with the
acceptor beads, resulting in light emission that was measured between 520
and 620 nm. (C) In AlphaScreen assay, the binding activity was measured as
the level of the AlphaScreen luminescence signal. Error bars represent
standard deviations from three independent experiments. (D)The
biotinylated-full-length HN, its deletion mutants and GST proteins were
separated by SDS-PAGE and transferred to PVDF membrane, followed by
immunoblotting with Strepavidin-HRP andibody (left panel) and indicated MAb
(right panel). (E) Summary of properties of selected MAbs. Immunoglobulin
isotyping was carried out with mouse monoclonal antibody isotyping test kit.
on the unexplored molecular link between the PIV3-HN and host
proteins.
Currently, cell-based production (e.g., E. coli system or
baculovirus-insect cell system) of recombinant virus proteins
has been widely used. However, it is often difﬁcult to pro-
duce sufﬁcient quantities of viral antigens in the conventional
cell-based system because many viral antigens are usually insol-
uble, cytotoxic, and are expressed in the inclusion body fraction.
In contrast, the cell-fee protein production system enables the
synthesis of toxic proteins that are otherwise excluded from
production in live cells. Among the cell-free approaches, the
wheat germ cell-free system employs a eukaryotic translation
system that warrants the synthesis of properly folded and bio-
logically active proteins similar to proteins that are expressed
in living mammalian cells (Endo and Sawasaki, 2005, 2006).
These advantages underscore the suitability and availability of
the wheat germ cell-free system for the generation of antigenic
proteins that can be used for animal immunizations to generate
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FIGURE 5 | No evident cross-reactivity of selected MAb to other
paramyxoviruses. (A) Schematic diagram of AlphaScreen assay. The
biotinylated partial HN proteins derived from several paramyxoviruses
containing CT, TM and stalk region were produced by wheat germ
cell-free system. (B,C) Speciﬁcity of MAbs was varidated by AlphaScreen
assay (B) and immunoblotting (C). In AlphaScreen assay, the binding
activity was measured as the level of the AlphaScreen luminescence
signal (B). Error bars represent standard deviations from three
independent experiments. The biotinylated partial HN proteins were
separated by SDS-PAGE and transferred to PVDF membrane, followed by
immunoblotting with either Strepavidin-HRP andibody (left panel) or
anti-HN MAbs (right panel; C).
MAbs. Our current study clearly demonstrated the beneﬁt of
using viral proteins synthesized by the wheat germ cell-free sys-
tem to efﬁciently produce the MAbs against the viral antigen.
Using this approach, we have created MAbs against HPIV3-HN
that detected both denatured and native forms of the anti-
gen. These MAbs were useful in various immunological assays
including ELISA, IF, immunoblotting, and immunoprecipita-
tion. Further careful studies of structural aspects are needed
to determine whether the MAb can affect the virus infectiv-
ity.
We identiﬁed Hsp70 as a putative HN binding protein. Sev-
eral previous studies demonstrated that Hsp70 was involved in
the regulation of other RNA viruses. Hsp70 is known to asso-
ciate with viral PB1 and PB2 subunits of inﬂuenza A virus,
and it negatively regulated the expression of viral proteins in
infected cells (Li et al., 2011). In another study, Hantavirus
infection induced the expression of HSP70 that interacted with
nucleocapsid protein and its overexpression suppressed viral infec-
tion in Vero E6 cells (Yu et al., 2009). In contrast, Hsp70 was
found to positively regulate rabies viral infection. Indeed, rabies
infection induced the cellular expression of Hsp70 and accu-
mulation in Negri body-like structures, which are the site of
viral transcription and replication. Inhibition of Hsp70 resulted
in a signiﬁcant decrease of viral mRNAs, viral proteins, and
virus particles (Lahaye et al., 2009, 2012). Taken together these
results indicated a pivotal role of Hsp70 in viral replication
and the pathogenicity of viral infection. Hsp70 binds and reg-
ulates many cellular proteins, as well as viral proteins (Pratt
and Toft, 2003; Mayer, 2005; Silver and Noble, 2012), and
the effects of Hsp70 on viral infection are diverse and unique
between different viral species or cell systems. Further studies
are required to investigate the precise molecular mechanism by
which the association of Hsp70 and HN proteins mediate HPIV3
replication.
We also found that PIV3-HN can interact with Serpin3a. Ser-
pin3a, as also known as alpha-1-antichymotrypsin, is a member
of serpin proteins involved in the inhibition of serine and other
types of proteases (Bauman et al., 2002). In humans, the majority
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FIGURE 6 | Proteomics analysis using selected MAb. (A) Schematic
diagram of proteomic analysis for the identiﬁcation of PIV3-HN-binding
protein. HPIV3-infected HeLa cell lysate was immunoprecipitated with
#21 MAb. The bound proteins were separated by SDS-PAGE and
analyzed by LC-Ms/Ms. (B) The panel shows the list of putative
HN-binding proteins identiﬁed by mass spectrometry analysis.
(C) FLAG-tagged HSP70, HSP90, tubulin alpha 1C, or SERPINA3 proteins
were mixed with HPIV3-HN. Samples were pull-down with the
streptavidin magnetic beads and the collected proteins were separated
by SDS-PAGE. The bound protein detected by immunoblotting analysis
with anti-FLAG antibody. The right arrows indicated the position of each
protein.
of serpins regulates the functions of proteases involved in the
response against body’s injuries such as coagulation, ﬁbrinol-
ysis, inﬂammation, wound healing and tissue repair. Serpins
have been also implicated in various pathologies in respiratory
system such as airway hyperresponsiveness (AHR) and asthma
(Sivaprasad et al., 2011). The physical interaction of HPIV3-
HN with serpin3a may be involved in hindering the function
of Serpin3a toward respiratory disorders. Further analysis may
shed new light on understanding the etiology of HPIV3-induced
asthma.
In summary, we utilized the wheat cell-free production system
to create and characterize MAbs that may be useful in various
immunological applications. Our newly-developed MAbs could
thus provide a valuable means to explore HPIV3 infection in
human cells.
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